Proteomic analysis at the bedside: early detection of cancer

被引:9
|
作者
Petricoin, EF [1 ]
Liotta, LA
机构
[1] US FDA, Ctr Biol Evaluat & Res, Div Therapeut Prot, FDA NCI Clin Prote Program, Bethesda, MD 20892 USA
[2] NCI, CCr, Pathol Lab, FDA NCI Clin Prote Program,NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1016/S1471-1931(02)00204-5
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Proteomic technologies promise to accelerate rapidly a new era in molecular medicine, especially in the detection and discovery of disease-related biomarkers. These technologies have no bigger impact than in the field of human cancer research. Beyond lifestyle-associated prevention strategies, early detection of cancer has the most profound impact on the ultimate course of the disease: the earlier the cancer is detected, the better the prognosis. Today, new proteomic technologies are being used to discover new diagnostic and prognostic biomarkers for the early detection and treatment of cancer that will have important implications at the bedside.
引用
收藏
页码:S30 / S34
页数:5
相关论文
共 50 条
  • [31] Early detection of colorectal cancer: A proteomic screening study for plasma biomarkers.
    Thorsen, Stine Buch
    Lundberg, Martin
    Assarsson, Erika
    Gee, Nick
    Knowles, Mick
    Christensen, Ib Jarle
    Nielsen, Hans J.
    Ekstrom, Bjorn
    Andersson, Claes
    Gustafsson, Mats
    Brunner, Nils
    Stenvang, Jan
    Fredriksson, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [32] Conventional and proteomic technologies for the detection of early stage malignancies: Markers for ovarian cancer
    Lee, Catherine J.
    Ariztia, Edgardo V.
    Fishman, David A.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2007, 44 (01) : 87 - 114
  • [33] Validation of salivary proteomic biomarkers for early detection of oral cancer in the Egyptian population
    Ghalwash, Dalia
    Ammar, Ahmed
    Abou-Bakr, Asmaa
    Diab, Al-Hassan
    El-Gawish, Ayman
    FUTURE SCIENCE OA, 2025, 11 (01):
  • [34] Blood analysis for early cancer detection
    Yu. Kiselev
    Physics of Particles and Nuclei, 2014, 45 : 344 - 346
  • [35] Blood analysis for early cancer detection
    Kiselev, Yu
    PHYSICS OF PARTICLES AND NUCLEI, 2014, 45 (01) : 344 - 346
  • [36] Plasma proteomic analysis for early prediction of response to chemotherapy in breast cancer
    Michlmayr, A.
    Bachleitner-Hofmann, T.
    Bergmann, M.
    Bauer, P.
    Oehler, R.
    FEBS JOURNAL, 2007, 274 : 258 - 258
  • [37] Proteomic Analysis of Maternal Urine for the Early Detection of Preeclampsia and Fetal Growth Restriction
    Bujold, Emmanuel
    Fillion, Alexandre
    Roux-Dalvai, Florence
    Scott-Boyer, Marie Pier
    Giguere, Yves
    Forest, Jean-Claude
    Gotti, Clarisse
    Laforest, Genevieve
    Guerby, Paul
    Droit, Arnaud
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (20)
  • [38] Identification of candidate biomarkers for the early detection of nasopharyngeal carcinoma by quantitative proteomic analysis
    Yang, Jing
    Zhou, Ming
    Zhao, Ran
    Peng, Shuping
    Luo, Zhaohui
    Li, Xiayu
    Cao, Li
    Tang, Ke
    Ma, Jian
    Xiong, Wei
    Fan, Songqing
    Schmitt, David C.
    Tan, Ming
    Li, Xiaoling
    Li, Guiyuan
    JOURNAL OF PROTEOMICS, 2014, 109 : 162 - 175
  • [39] Multi-cancer early detection (MCED) tests: prioritizing equity from bench to bedside
    Miller, Sarah J.
    Sly, Jamilia R.
    Rolfo, Christian
    Mack, Philip
    Villanueva, Augusto
    Mazor, Melissa
    Weber, Ellerie
    Lin, Jenny J.
    Smith, Cardinale B.
    Taioli, Emanuela
    HEALTH AFFAIRS SCHOLAR, 2024, 2 (05):
  • [40] Proteomic approach to discover new biomarkers in saliva for early detection of breast cancer in women
    Sinha, Raghu
    Baatz, John
    Null, Kevin
    Smith, J. Stanley
    Baker, Maria
    Pells, Molly
    Mauger, David
    Handley, Nancy
    Strickler, Annette
    Kovach, Judy
    Webb, Chanty
    Mottilla, Shirlynn
    George, Nancy
    Jenkins, Rebecca
    CANCER RESEARCH, 2009, 69